Compare · CCM vs LFST
CCM vs LFST
Side-by-side comparison of Concord Medical Services Holdings Limited (CCM) and LifeStance Health Group Inc. (LFST): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CCM and LFST operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- LFST is the larger of the two at $4.82B, about 269.5x CCM ($17.9M).
- Over the past year, CCM is down 19.4% and LFST is up 143.2% - LFST leads by 162.6 points.
- LFST has hit the wire 8 times in the past 4 weeks while CCM has been quiet.
- LFST has more recent analyst coverage (17 ratings vs 0 for CCM).
- Company
- Concord Medical Services Holdings Limited
- LifeStance Health Group Inc.
- Price
- $4.41-10.55%
- $12.60-1.52%
- Market cap
- $17.9M
- $4.82B
- 1M return
- -2.00%
- +5.97%
- 1Y return
- -19.38%
- +143.24%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2024
- 2021
- News (4w)
- 0
- 8
- Recent ratings
- 0
- 17
Concord Medical Services Holdings Limited
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company operates in Network and Hospital segments. The company's services comprise linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, and diagnostic imaging services. It also offers other treatments and diagnostic services comprising electroencephalography for the diagnosis of epilepsy; thermotherapy for pain relief after radiotherapy and chemotherapy; ultrasound therapy for the treatment of cancer; stereotactic radiofrequency ablation for the treatment of Parkinson's disease; and refraction and tonometry for the diagnosis of ophthalmic conditions. In addition, the company provides clinical support services, including developing treatment protocols for doctors; and organizing joint diagnosis between doctors in its network and clinical research. Further, it offers radiotherapy and diagnostic equipment leasing and management services to hospitals, as well as tele-consulting services; and sells medical equipment. Additionally, the company establishes the Beijing Proton Medical Center that provides radiotherapy treatment options to cancer patients; and other specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of June 30, 2019, it operated a network of 30 centers based in 20 hospitals in 20 cities across 13 provinces and administrative regions in China. Concord Medical Services Holdings Limited was incorporated in 2007 and is headquartered in Beijing, the People's Republic of China.
LifeStance Health Group Inc.
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. The company offers patients care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was incorporated in 2021 and is based in Scottsdale, Arizona.
Latest CCM
- New insider Shi Botao claimed ownership of 477,000 units of Class A ordinary shares (SEC Form 3)
- SEC Form 6-K filed by Concord Medical Services Holdings Limited
- SEC Form 6-K filed by Concord Medical Services Holdings Limited
- SEC Form 6-K filed by Concord Medical Services Holdings Limited
- SEC Form 6-K filed by Concord Medical Services Holdings Limited
- Concord Medical Files Annual Report on Form 20-F for the Fiscal Year 2025
- SEC Form 20-F filed by Concord Medical Services Holdings Limited
- SEC Form 6-K filed by Concord Medical Services Holdings Limited
- SEC Form 3 filed by new insider Yang Jianyu
- SEC Form 3 filed by Concord Medical Services Holdings Limited
Latest LFST
- LifeStance Health Group Announces Pricing of Secondary Public Offering
- SEC Form 424B7 filed by LifeStance Health Group Inc.
- LifeStance Health Group Announces Launch of Secondary Public Offering
- Chief Technology Officer Paunovich Vukasin sold $541,402 worth of shares (42,067 units at $12.87), decreasing direct ownership by 17% to 205,379 units (SEC Form 4)
- Chief Executive Officer Bourdon David disposed of 150,000 shares, decreasing direct ownership by 11% to 1,248,247 units (SEC Form 4)
- LifeStance to Present at Upcoming Investor Conferences
- Chief People Officer Varanakis Ann covered exercise/tax liability with 8,156 shares, decreasing direct ownership by 2% to 413,881 units (SEC Form 4) (for withholding tax)
- Director Deluca Teresa sold $95,100 worth of shares (7,500 units at $12.68), decreasing direct ownership by 7% to 97,093 units (SEC Form 4) (withholding tax)
- Director Deluca Teresa sold $249,993 worth of shares (20,441 units at $12.23), decreasing direct ownership by 16% to 104,593 units (SEC Form 4)
- SEC Form 144 filed by LifeStance Health Group Inc.